FLRT1 Gene SPG68 FLRT1 Related NGS Genetic DNA Test
Comprehensive Genetic Testing for Hereditary Spastic Paraplegia
The FLRT1 Gene SPG68 FLRT1 Related NGS Genetic DNA Test represents a breakthrough in neurological genetic diagnostics, offering precise detection of mutations associated with hereditary spastic paraplegia type 68. This advanced genetic analysis utilizes next-generation sequencing technology to provide comprehensive insights into FLRT1 gene variations that contribute to progressive neurological conditions affecting motor function and mobility.
What Does This Test Measure and Detect?
This sophisticated genetic test specifically targets the FLRT1 (Fibronectin Leucine Rich Transmembrane protein 1) gene, which plays a crucial role in neuronal development and axonal guidance. The test detects:
- Pathogenic mutations in the FLRT1 gene associated with SPG68
- Single nucleotide variants (SNVs) and small insertions/deletions
- Copy number variations affecting FLRT1 gene function
- Novel genetic variants with potential clinical significance
- Inheritance patterns for family genetic counseling
Who Should Consider FLRT1 Genetic Testing?
This test is particularly recommended for individuals experiencing:
- Progressive lower limb spasticity and stiffness
- Gait disturbances and walking difficulties
- Muscle weakness in the legs
- Family history of hereditary spastic paraplegia
- Unexplained neurological symptoms with spastic components
- Children with developmental delays and spasticity
- Individuals planning pregnancy with family history of SPG68
Clinical Benefits of FLRT1 Genetic Testing
Undergoing FLRT1 genetic testing provides numerous clinical advantages:
- Accurate Diagnosis: Confirms or rules out SPG68 with high precision
- Treatment Guidance: Informs targeted therapeutic approaches
- Prognostic Information: Helps predict disease progression
- Family Planning: Enables informed reproductive decisions
- Early Intervention: Facilitates timely management strategies
- Genetic Counseling: Provides comprehensive family risk assessment
Understanding Your Test Results
Your FLRT1 genetic test results will be carefully interpreted by our expert geneticists and neurologists:
- Positive Result: Indicates the presence of pathogenic FLRT1 mutation(s) consistent with SPG68 diagnosis
- Negative Result: Suggests no detectable FLRT1 mutations, though other genetic causes may need investigation
- Variant of Uncertain Significance: Identifies genetic changes requiring further clinical correlation
- Carrier Status: Determines if you carry a single copy of FLRT1 mutation
All results include detailed interpretation and recommendations for next steps, including consultation with our specialized neurologists and genetic counselors.
Test Pricing and Availability
| Test Component | Price (USD) |
|---|---|
| Discount Price | $500 |
| Regular Price | $700 |
Nationwide Testing Availability
We have comprehensive testing facilities across the United States, with branches in all major cities including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our state-of-the-art laboratories ensure consistent, high-quality results regardless of your location.
Take Control of Your Neurological Health Today
Don’t let uncertainty about hereditary spastic paraplegia affect your quality of life. Our FLRT1 Gene SPG68 NGS Genetic DNA Test provides the clarity you need for informed medical decisions and family planning. With rapid 3-4 week turnaround time and multiple sample collection options including blood, extracted DNA, or FTA card blood spots, getting tested has never been more convenient.
Call or WhatsApp us today at +1(267) 388-9828 to schedule your genetic counseling session and book your FLRT1 genetic test. Our dedicated team is ready to guide you through every step of the testing process and provide the expert support you deserve.
